Erel Joffe MD MSc
Cited by
Cited by
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
Y Herishanu, I Avivi, A Aharon, G Shefer, S Levi, Y Bronstein, M Morales, ...
Blood, The Journal of the American Society of Hematology 137 (23), 3165-3173, 2021
Evaluation of a problem-specific SBAR tool to improve after-hours nurse-physician phone communication: a randomized trial
E Joffe, JP Turley, KO Hwang, TR Johnson, CW Johnson, EV Bernstam
The Joint Commission Journal on Quality and Patient Safety 39 (11), 495-AP6, 2013
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
S Borchmann, E Joffe, CH Moskowitz, AD Zelenetz, A Noy, CS Portlock, ...
Blood, The Journal of the American Society of Hematology 133 (20), 2121-2129, 2019
A benchmark comparison of deterministic and probabilistic methods for defining manual review datasets in duplicate records reconciliation
E Joffe, MJ Byrne, P Reeder, JR Herskovic, CW Johnson, AB McCoy, ...
Journal of the American Medical Informatics Association 21 (1), 97-104, 2014
C-reactive protein to distinguish pneumonia from acute decompensated heart failure
E Joffe, D Justo, N Mashav, M Swartzon, H Gur, S Berliner, Y Paran
Clinical biochemistry 42 (16-17), 1628-1634, 2009
C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia
D Justo, S Lachmi, N Saar, E Joffe, L Atzmony, N Mashav, O Henis, ...
European journal of internal medicine 20 (5), 518-521, 2009
The value of PET/CT in detecting bone marrow involvement in patients with follicular lymphoma
C Perry, H Lerman, E Joffe, N Sarid, O Amit, I Avivi, M Kesler, J Ben-Ezra, ...
Medicine 95 (9), 2016
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
CL Batlevi, F Sha, A Alperovich, A Ni, K Smith, Z Ying, JD Soumerai, ...
Blood cancer journal 10 (7), 1-12, 2020
The value of electrophysiologic study in decision-making regarding the need for pacemaker implantation after TAVI
O Tovia-Brodie, Y Ben-Haim, E Joffe, A Finkelstein, A Glick, R Rosso, ...
Journal of Interventional Cardiac Electrophysiology 48 (2), 121-130, 2017
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
AM Intlekofer, E Joffe, CL Batlevi, P Hilden, J He, VE Seshan, AD Zelenetz, ...
Blood cancer journal 8 (6), 1-10, 2018
Duplicate patient records–implication for missed laboratory results
E Joffe, CF Bearden, MJ Byrne, EV Bernstam
AMIA annual symposium proceedings 2012, 1269, 2012
Recurrent hospitalizations with moderate to severe hyponatremia in older adults and its associated mortality
S Gefen, E Joffe, H Mayan, D Justo
European journal of internal medicine 25 (7), 624-628, 2014
Expert guided natural language processing using one-class classification
E Joffe, EJ Pettigrew, JR Herskovic, CF Bearden, EV Bernstam
Journal of the American Medical Informatics Association 22 (5), 962-966, 2015
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
D Sermer, C Batlevi, ML Palomba, G Shah, RJ Lin, MA Perales, M Scordo, ...
Blood advances 4 (19), 4669-4678, 2020
Initial results of a multicenter, investigator initiated study of MRD driven time limited therapy with zanubrutinib, obinutuzumab, and venetoclax.
JD Soumerai, AR Mato, J Carter, A Dogan, E Hochberg, JA Barnes, ...
Journal of Clinical Oncology 38 (15_suppl), 8006-8006, 2020
Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma
CL Batlevi, F Sha, A Alperovich, A Ni, K Smith, Z Ying, JF Gerecitano, ...
European Journal of Cancer 126, 78-90, 2020
Clinical trials in the genomic era
E Joffe, A Iasonos, A Younes
Journal of Clinical Oncology 35 (9), 1011, 2017
Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study …
Y Herishanu, N Goldschmidt, O Bairey, R Ruchlemer, R Fineman, ...
Haematologica 100 (5), 662, 2015
Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphoma
E Joffe, D Rosenberg, U Rozovski, C Perry, I Kirgner, S Trestman, O Gur, ...
Bone marrow transplantation 53 (1), 29-33, 2018
MRD-driven time limited therapy with zanubrutinib, obinutuzumab, and venetoclax (BOVen) in previously untreated chronic lymphocytic leukemia
JD Soumerai, AR Mato, J Carter, A Dogan, EP Hochberg, JA Barnes, ...
Blood 136 (S1), 1307, 2020
The system can't perform the operation now. Try again later.
Articles 1–20